Assignee
ST IP HOLDING AG
CH·6 granted patents·9 pending applications·2 citations·filing 2014–2022
Top patents by PatentIndex Score
15 records- 0171US2021206752A1Methods for preparing oltiprazST IP HOLDING AG·Filed 2021·Application pending·0 cites
- 0270US11426403B2Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using sameST IP HOLDING AG·Filed 2019·Granted Aug 30, 2022·1 cites·19 claims
- 0369US10968207B2Methods for preparing oltiprazST IP HOLDING AG·Filed 2020·Granted Apr 6, 2021·0 cites·9 claims
- 0467US10328090B2Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereofST IP HOLDING AG·Filed 2016·Granted Jun 25, 2019·1 cites·20 claims
- 0566US2020172522A1Methods for preparing oltiprazST IP HOLDING AG·Filed 2020·Application pending·0 cites
- 0662US12312343B2Rotomeric isomers of 4-alkyl-5-heteroaryl-3H-1,2-dithiole-3-thionesST IP HOLDING AG·Filed 2021·Granted May 27, 2025·0 cites·23 claims
- 0760US2019084971A1Methods for preparing oltiprazST IP HOLDING AG·Filed 2018·Application pending·0 cites
- 0860US2023255961A1Rotomeric Isomers of 4-Alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-ThionesST IP HOLDING AG·Filed 2022·Application pending·0 cites
- 0958US2015031701A1Compositions and methods for preventing and treating mucositis and weight lossST IP HOLDING AG·Filed 2014·Application pending·0 cites
- 1056US11185544B2Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using sameST IP HOLDING AG·Filed 2019·Granted Nov 30, 2021·0 cites·23 claims
- 1155US2022296589A1Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using SameST IP HOLDING AG·Filed 2021·Application pending·0 cites
- 1255US2018311237A1Compositions and methods for preventing and treating mucositis and weight lossST IP HOLDING AG·Filed 2017·Application pending·0 cites
- 1352US2016376259A1Methods for Preparing OltiprazST IP HOLDING AG·Filed 2015·Application pending·0 cites
- 1451US2021052580A1Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using SameST IP HOLDING AG·Filed 2020·Application pending·0 cites
- 1550US11135220B1Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thioneST IP HOLDING AG·Filed 2020·Granted Oct 5, 2021·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →